Georgina Morley, PhD, MSc, RN and Annie Sharon Fox, MA
This series of 3 paintings of figures in a bath explores emotional responses of persons experiencing or responding to others’ moral distress. Intricately tied together and connected through time and space, the bodies represented suggest a complex web of relationships between clinicians and patients.
AMA J Ethics. 2019;21(5):E457-460. doi:
10.1001/amajethics.2019.457.
Rachel Koch, MD, John G. Meara, MD, DMD, MBA, and Anji E. Wall, MD, PhD
Single-procedure interventions with minimal follow-up and clear quality-of-life gain are well suited for surgical mission trips. But not all risks and benefits are easily assessed.
AMA J Ethics. 2019;21(9):E729-734. doi:
10.1001/amajethics.2019.729.
How do we determine what a fair price for a life-saving prescription medication should be? This month, we discuss what is means for a price to be “fair” and explore the current legal and economic landscape of prescription drug pricing in the US.
Antonio Yaghy, MD, Jerry A. Shields, MD, and Carol L. Shields, MD
Two digital photo-paintings address AI applications in medicine narratively and visually, with special emphasis on communication, compassion, and competence.
AMA J Ethics. 2019;21(11):E1009-1013. doi:
10.1001/amajethics.2019.1009.
Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019;21(10):E844-851. doi:
10.1001/amajethics.2019.844.